본문으로 건너뛰기

Main Research Achievements

Research Institute of Samjin Pharmaceutical Co., Ltd.
is always aiming for the best

Code Indication Development Stage Achievement
SJ3991 HIV IND Approved to USA-FDA Licensed-Out
SJ3902 Cancer Preclinical Licensed-Out
Clopidogrel Bisulfate Platlet Launched API of Platless Tablet
Development and export of raw material of spherical clopidogrel bisulfate
Export of formulation technology for Platless Tablets

PLATLESS TAB

* High purity
* Uniform particle size
* Excellent physico-chemical properties
* Outstanding stability